Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

CardiaTec Biosciences uses large-scale human cardiac multiomics and clinical data to identify new targets and therapies for cardiovascular disease. The company combines AI and computational modeling…

CardiaTec Biosciences uses large-scale human cardiac multiomics and clinical data to identify new targets and therapies for cardiovascular disease. The company combines AI and computational modeling…
What they do: Human cardiac tissue multiomics + AI to discover cardiovascular therapeutics
Origin: Spinout from the Han Lab, University of Cambridge
Founders: Raphael Peralta (CEO), Thelma Zablocki (COO), Namshik Han (CTO/co-founder)
Team size: 17 employees
Funding: $6.5M seed (after $1.8M pre-seed); total funding listed ≈ $8.169M
Cardiovascular disease drug discovery and target identification
2021
Biotechnology Research
$1.8M
Prior to seed financing
$6.5M
Seed round announced in September 2024
“Seed round led by Montage Ventures with participation from Continuum Health Ventures, Laidlaw Ventures, Apex Ventures and angel investors”
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
65,000+
Open Roles
1,600+
New This Week
| Company |
|---|